Canine Science

Heart Conditions in Dogs

Explore the science behind heart conditions in dogs — from evolutionary cardiac adaptations to breed-specific risks, diagnostics, and what modern research reveals.

By Tom Renshaw · Published 7 June 2026 · Updated 16 October 2026
Heart Conditions in Dogs

Quick Answer: Heart conditions in dogs are diseases that impair the heart's ability to pump blood effectively. The two most prevalent forms are mitral valve disease (MVD), which primarily affects small breeds and involves degeneration of the mitral valve leaflets, and dilated cardiomyopathy (DCM), which predominantly affects large and giant breeds and involves progressive weakening of the heart muscle. Approximately 10% of all dogs develop some form of heart disease during their lifetime, with MVD accounting for roughly 75% of canine cardiac cases. Early detection through routine veterinary auscultation and echocardiography dramatically improves outcomes.

Why Do Dogs Develop Heart Conditions? The Physiological Mechanism

The canine heart is a four-chambered muscular pump operating on electrical impulses originating from the sinoatrial (SA) node. When heart conditions develop in dogs, the failure typically occurs at one of three levels: valvular incompetence (valves fail to seal, causing regurgitation), myocardial dysfunction (the heart muscle weakens or stiffens), or electrical conduction abnormalities (arrhythmias disrupt coordinated pumping).

In mitral valve disease — the most common heart condition in dogs — the mitral valve leaflets progressively thicken and develop nodular changes through a process called myxomatous degeneration. The collagen and glycosaminoglycan composition of the valve matrix changes, causing the leaflets to become floppy and unable to form a tight seal. Blood then regurgitates from the left ventricle back into the left atrium with each contraction, increasing atrial pressure and eventually leading to congestive heart failure (CHF).

According to the Merck Veterinary Manual, myxomatous mitral valve disease (MMVD) progresses through stages classified by the ACVIM consensus statement: Stage A (at-risk breeds with no detectable disease), Stage B1 (murmur present but no cardiac enlargement), Stage B2 (murmur with cardiac remodeling but no clinical signs), and Stage C (current or past signs of heart failure).

In dilated cardiomyopathy, the mechanism differs fundamentally. The cardiomyocytes (heart muscle cells) undergo progressive loss of contractile function, often linked to genetic mutations affecting proteins like titin and pyruvate dehydrogenase kinase 4 (PDK4). The ventricular walls thin and the chambers dilate, reducing ejection fraction — the percentage of blood pumped out with each beat drops from a normal 45-65% to as low as 15-25% in advanced DCM.

The Evolutionary Context: Canine Cardiac Adaptations from Wolf to Domestic Dog

Evolutionary Perspective: The ancestral wolf's cardiovascular system evolved for high-endurance pursuit predation — sustained trotting over 20-40 miles daily with bursts of sprinting at 35-40 mph. This demanded exceptional cardiac output, with a wolf's heart comprising approximately 0.75-0.85% of total body weight (compared to roughly 0.5-0.6% in many modern domestic dog breeds). Selective breeding over the past 15,000-30,000 years has dramatically altered body size, conformation, and metabolic demands — creating cardiac vulnerabilities that simply didn't exist in ancestral populations.

The extreme body size diversification in domestic dogs — from the 4-pound Chihuahua to the 200-pound English Mastiff — occurred faster than cardiac anatomy could adapt through natural selection. Small breeds were selected for compact skulls and shortened limbs, but their heart valves were subjected to proportionally higher hemodynamic stress relative to valve surface area. This may partly explain why Cavalier King Charles Spaniels and other toy breeds show such extraordinarily high MVD prevalence — some estimates suggest over 50% of Cavaliers develop MVD by age 5, and nearly all are affected by age 10.

Large and giant breeds, conversely, were selected for massive body size without corresponding increases in cardiac muscle density. The rapid growth trajectories of breeds like Great Danes and Irish Wolfhounds place extraordinary metabolic demands on developing myocardium, and the genetic bottlenecks created by breed-specific selection have concentrated deleterious mutations affecting cardiac structure. A study published in the Journal of Veterinary Internal Medicine found that Doberman Pinschers carry a prevalence of DCM approaching 58% over their lifetime, linked to identifiable genetic mutations.

How Is the Canine Heart Different from the Human Heart?

While dogs and humans share the same basic four-chambered cardiac architecture, several physiological differences directly affect how heart conditions manifest in dogs:

Feature Dogs Humans
Resting Heart Rate 60-160 bpm (varies by size) 60-100 bpm
Most Common Valve Disease Mitral valve (myxomatous degeneration) Aortic valve (calcific stenosis)
Coronary Artery Disease Extremely rare — dogs rarely develop atherosclerotic plaques Leading cause of heart attacks
Heart Failure Mechanism Volume overload (regurgitation) predominates Pressure overload and ischemic damage predominate
Diet-Related DCM Link Investigated link to grain-free/legume-rich diets (FDA, 2018-ongoing) Not applicable
Cardiac Biomarkers Used NT-proBNP, cTnI (Cardiopet® proBNP test) BNP, troponin, CK-MB

One critical distinction: dogs almost never suffer "heart attacks" (myocardial infarctions) the way humans do. Their coronary arteries have extensive collateral circulation, and dogs rarely develop the cholesterol-driven atherosclerotic plaques that occlude human coronary vessels. When a dog with heart disease collapses suddenly, the cause is more likely a fatal arrhythmia or acute heart failure — not a blocked artery.

Breed-Specific Heart Conditions: What the Data Shows

Heart conditions in dogs are not distributed equally across breeds. Genetic predisposition plays a dominant role, and understanding your dog's breed-specific risk profile can guide screening schedules and early intervention.

Breed Primary Condition Prevalence / Key Data Recommended Screening
Cavalier King Charles Spaniel Mitral Valve Disease ~50% affected by age 5; nearly 100% by age 10 Annual auscultation from age 1; echocardiogram by age 3
Doberman Pinscher Dilated Cardiomyopathy Up to 58% lifetime prevalence; occult (silent) phase lasts 1-3 years Annual Holter monitor + echocardiogram from age 3; genetic test available (PDK4 + DCM2)
Great Dane DCM / Atrial Fibrillation ~15-20% develop DCM; males at higher risk Baseline echocardiogram at age 2-3; annual thereafter
Boxer Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) ~6-10% prevalence; linked to striatin gene mutation Annual Holter from age 3; genetic test (striatin deletion) available
Miniature Schnauzer Sick Sinus Syndrome Overrepresented; causes brady-tachy arrhythmias ECG evaluation if syncope episodes occur
Cocker Spaniel DCM (taurine-responsive in some cases) Moderate prevalence; some cases reverse with taurine supplementation Plasma taurine levels + echocardiogram if murmur detected

Can Dogs Develop Heart Disease from Their Diet?

This question has driven significant cardiac research since 2018, when the U.S. FDA began investigating a potential link between grain-free diets containing high proportions of peas, lentils, chickpeas, and potatoes (often listed among the first 10 ingredients) and DCM in dogs not traditionally predisposed to the condition. Breeds like Golden Retrievers, Labrador Retrievers, and mixed-breed dogs — which historically had very low DCM rates — were presenting with DCM-like cardiac changes that in some cases partially reversed when diet was changed and taurine was supplemented.

The mechanism is not yet fully understood as of 2026. Leading hypotheses include:

  • Taurine depletion: Legumes and certain fibers may bind bile acids in the gut, increasing taurine excretion. Taurine is critical for myocardial calcium handling and osmoregulation.
  • Amino acid imbalance: Diets high in plant proteins may have lower bioavailability of sulfur-containing amino acids (methionine, cysteine) that serve as taurine precursors.
  • Unknown dietary factor: Some researchers suspect a cardiotoxic compound in certain legume-based formulations that has yet to be identified.

The FDA's investigation remains ongoing. Veterinary cardiologists generally recommend choosing diets that meet AAFCO feeding trial standards (not just formulation analysis), that are manufactured by companies employing full-time veterinary nutritionists, and that have published peer-reviewed feeding studies. Brands like Purina, Royal Canin, Hill's, and Iams have the most robust cardiac safety data.

Practical Diet Guidance: If your dog is on a boutique, exotic-protein, or grain-free (BEG) diet, discuss the risks with your veterinarian. A plasma taurine test costs approximately $45-75 and can identify deficiency. An NT-proBNP cardiac biomarker test (Cardiopet® proBNP, approximately $80-150) can screen for early myocardial stress before clinical signs appear.

Common Misconceptions About Heart Conditions in Dogs

Myth Fact
"A coughing dog just has kennel cough or allergies." A persistent, dry, honking cough — especially at night or after excitement — is a hallmark sign of left-sided heart enlargement compressing the mainstem bronchi. This warrants immediate cardiac evaluation.
"Heart murmurs always mean heart disease." Puppies commonly have innocent (physiologic) murmurs that resolve by 4-6 months. Some adult dogs have low-grade murmurs (Grade I-II) without significant structural disease. Echocardiography is needed to determine clinical significance.
"If my dog is active and eating well, their heart must be fine." Dogs are remarkably effective at compensating for cardiac dysfunction. The occult phase of DCM in Dobermans can last 1-3 years with zero outward symptoms. Sudden death from ventricular arrhythmia can occur before any clinical signs appear.
"Heartworm prevention isn't necessary if my dog stays indoors." Mosquitoes transmit heartworm and can easily enter homes. The American Heartworm Society reports infections in all 50 states. Heartworm disease causes pulmonary hypertension and right-sided heart failure — and treatment (melarsomine) costs $1,000-3,000+ and carries significant risk.
"Supplements and natural remedies can replace heart medications." While omega-3 fatty acids (EPA/DHA at 30-40 mg/kg combined) show evidence for reducing cardiac cachexia, they do NOT replace pimobendan, ACE inhibitors, or diuretics. Discontinuing prescribed medications based on supplement use can be fatal.

What Does It Mean When My Dog Shows These Signs?

Recognizing the clinical signs of heart conditions in dogs requires understanding what each symptom represents physiologically. Here's a symptom-to-mechanism breakdown:

  • Exercise intolerance (refusing walks, lagging behind): Reduced cardiac output means skeletal muscles receive insufficient oxygenated blood during exertion. The dog isn't being "lazy" — they literally cannot meet metabolic demand.
  • Rapid or labored breathing at rest (>30 breaths/minute while sleeping): Elevated left atrial pressure causes pulmonary venous congestion. Fluid accumulates in or around the lungs (pulmonary edema or pleural effusion). Count your dog's sleeping respiratory rate — this is one of the most valuable home-monitoring tools available.
  • Syncope (fainting episodes): A sudden drop in cardiac output — often from an arrhythmia — causes temporary cerebral hypoperfusion. The dog collapses, typically regains consciousness within seconds to minutes. This is a medical emergency requiring Holter monitoring.
  • Abdominal distension (ascites): Right-sided heart failure causes blood to back up into the hepatic and systemic venous system. Fluid weeps from engorged liver surfaces and peritoneal capillaries into the abdominal cavity. This indicates advanced disease.
  • Weight loss with muscle wasting (cardiac cachexia): Pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6) are elevated in chronic heart failure, driving catabolic metabolism. The dog loses muscle mass despite adequate caloric intake.

When to Call Your Veterinarian Immediately: If your dog shows any of the following, seek emergency veterinary care: respiratory rate exceeding 40 breaths/minute at rest, blue-tinged gums or tongue (cyanosis), sudden collapse or inability to stand, coughing up pink frothy fluid (pulmonary edema), or a distended abdomen accompanied by labored breathing. These signs suggest acute decompensated heart failure, and treatment within hours significantly improves survival.

Diagnostic Science: How Veterinarians Evaluate Canine Heart Disease

Modern veterinary cardiology employs a layered diagnostic approach. Here's what to expect and what each test reveals:

1. Auscultation (stethoscope exam): Your veterinarian listens for heart murmurs, graded I-VI based on intensity. A Grade III or higher murmur in an adult dog warrants further investigation. Cost: included in a standard exam ($50-90).

2. Thoracic Radiographs (X-rays): Reveal cardiac silhouette size (vertebral heart score), pulmonary vessel engorgement, and pulmonary edema or pleural effusion. Cost: $150-350 for a 3-view study.

3. Echocardiography (ultrasound of the heart): The gold standard for diagnosing structural heart disease. Measures chamber dimensions, wall thickness, valve morphology, ejection fraction, and regurgitant jet severity. A board-certified veterinary cardiologist typically charges $350-600 for a complete echo with measurements and report.

4. Electrocardiogram (ECG): Records electrical activity to identify arrhythmias. A standard 2-minute ECG costs $50-100. A 24-hour Holter monitor (continuous ECG recording) costs $250-500 and is critical for breeds prone to silent arrhythmias like Dobermans and Boxers.

5. Cardiac Biomarkers:

  • NT-proBNP (Cardiopet® proBNP): Released when myocardial cells are stretched. Elevated levels indicate cardiac stress. Useful for distinguishing cardiac from respiratory causes of coughing. Cost: $80-150.
  • cTnI (cardiac troponin I): Released when cardiomyocytes are damaged. Elevated in myocarditis, DCM, and some systemic diseases affecting the heart. Cost: $60-120.

Is Treatment Effective? Prognosis and Management Science

Treatment efficacy depends heavily on the specific condition and stage at diagnosis. The landmark EPIC Study (Evaluation of Pimobendan In dogs with Cardiomegaly), published in the Journal of Veterinary Internal Medicine, demonstrated that starting pimobendan (Vetmedin®) in dogs with Stage B2 MMVD — those with enlarged hearts but no clinical signs yet — extended the time to onset of heart failure or cardiac death by a median of 15 months compared to placebo. This was a practice-changing finding.

Standard heart failure management typically involves a combination protocol:

  • Pimobendan (0.25-0.3 mg/kg twice daily): A positive inotrope and vasodilator that improves contractility without increasing oxygen demand. Cost: approximately $40-90/month depending on dog size.
  • Furosemide (1-4 mg/kg twice to three times daily): A loop diuretic that removes excess fluid from the lungs and tissues. Cost: $15-40/month.
  • Enalapril or Benazepril (0.25-0.5 mg/kg once to twice daily): ACE inhibitors that reduce afterload and slow cardiac remodeling. Cost: $15-45/month.
  • Spironolactone (1-2 mg/kg twice daily): An aldosterone antagonist that reduces fibrosis and fluid retention. Cost: $20-50/month.

For dogs in congestive heart failure (Stage C), median survival with appropriate quadruple therapy is approximately 6-12 months, though individual outcomes range from weeks to several years. Quality of life during this period is generally good when medications are consistently administered and recheck evaluations occur every 3-6 months.

Always consult your veterinarian or a board-certified veterinary cardiologist before making any decisions about cardiac medications. Dosages, drug combinations, and monitoring schedules must be individualized based on your dog's specific condition, kidney function, electrolyte levels, and concurrent diseases.

Frequently Asked Questions

Can dogs survive heart disease with a good quality of life?

Yes. Many dogs with early-stage heart conditions (Stages B1 and B2) live for years without clinical signs, especially with early pimobendan intervention. Even dogs in Stage C heart failure often maintain good appetite, enjoy gentle walks, and interact normally with their families for months to years with proper medication management. The key is consistent medication administration and regular veterinary monitoring.

How do dogs sense that something is wrong with their own heart?

Dogs don't conceptualize "heart disease," but they do perceive its physiological consequences. Reduced cardiac output causes exercise fatigue — a dog will self-limit activity because exertion triggers dyspnea (air hunger) or presyncope (near-fainting). Baroreceptors in the carotid sinus and aortic arch detect blood pressure changes, and chemoreceptors sense blood oxygen drops. These trigger compensatory responses like increased respiratory rate and reduced activity. Dogs are exceptionally good at masking discomfort, which is why objective measures like sleeping respiratory rate counting are more reliable than behavioral observation alone.

Is heart disease in dogs hereditary?

Many forms are strongly hereditary. MMVD in Cavaliers has a known polygenic inheritance pattern. DCM in Dobermans is linked to at least two identified genetic mutations (PDK4 deletion and a separate locus termed DCM2). ARVC in Boxers is associated with a striatin gene deletion. The AKC recommends that breeders of predisposed breeds perform cardiac screening through the OFA (Orthopedic Foundation for Animals) cardiac registry, which requires echocardiographic evaluation by a board-certified cardiologist. If you're purchasing a puppy from a predisposed breed, ask for OFA cardiac clearance certificates on both parents.

Is a grain-free diet causing heart disease in my dog?

The FDA's investigation into diet-associated DCM has not yet established definitive causation, but the association is concerning enough that most veterinary cardiologists recommend avoiding boutique, exotic-protein, and grain-free (BEG) diets until more data is available. If your dog has been eating a grain-free diet, discuss a transition to an AAFCO feeding-trial-tested diet with your veterinarian and consider baseline cardiac screening including NT-proBNP testing.

What does it mean when my dog's heart murmur gets louder?

Murmur intensity (grade) generally correlates with the severity of valvular regurgitation, but not always. A murmur can increase in grade as valve degeneration progresses, but it can also paradoxically decrease in very advanced disease when cardiac output drops so low that there isn't enough blood flow to generate a loud murmur. This is why echocardiographic monitoring — not murmur grade alone — should guide treatment decisions.

Written by

Tom Renshaw

All our authors care for dogs every day — read more of their work on the authors page.